Antineoplastic effects of nutrient mixture on Raji and Jurkat T cells: The two highly aggressive non Hodgkin's lymphoma cell lines

Experimental Oncology

Volumn 31, Issue 3, 2009, Pages 149-155

  Roomi, M W ^a   Bhanap, B A ^a   Roomi, N W ^a   Rath, M ^a   Niedzwiecki, A ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

Apoptosis; Burkitt's lymphoma; Jurkat T cells; MMP; Nutrient mixture; Raji cells

Indexed keywords

ASCORBIC ACID; GELATINASE B; GREEN TEA EXTRACT; LYSINE; MATRIGEL; MATRIX METALLOPROTEINASE; PROLINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FOOD INTAKE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; METASTASIS; NONHODGKIN LYMPHOMA; NUTRITIONAL DEFICIENCY; PROTEIN EXPRESSION; RAJI CELL; T CELL LYMPHOMA; T LYMPHOCYTE; ZYMOGRAPHY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ASCORBIC ACID; BURKITT LYMPHOMA; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; HUMANS; LAMININ; LYMPHOMA, T-CELL; LYSINE; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PROLINE; PROTEOGLYCANS; TEA; TUMOR CELLS, CULTURED;

EID: 72449139622     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. American Cancer Society http://www.cancer.org//doc-root/home/index.asp? level=0
2. Rodgers G, Young N. Handbook of clinical hematology. Philadelphia: Lippincott Williams & Wilkins, 2005: 199-220.
3. Kuittinen O. Matrix Metalloprietinsae-2 (MMP-2) and -9 (MMP-9). In: Hematological Malignancies, 2003ISBN: 951-42-6942-X (URL: http://herkules.oulu. fi/isbn951426942X/)
4. Rath M, Pauling L. Plasmin-induced proteolysis and the role of apoprotein(a), lysine, and synthetic lysine analogs. J Orthomol Med 1992; 7: 17-23.
5. Verma R, Hansch C. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem 2007; 15: 2223-2268 (Pubitemid 46240907)
6. Kraiem Z, Korem S. Matrix metalloproteinases and the thyroid. Thyroid 2000; 10: 1061-1069
7. Kleiner D, Stetler-Stevenson W. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999; 43 Suppl: S42-51.
8. Roomi MW, Ivanov V, Kalinovsky T, et al. In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080. Med Oncol 2006; 23: 105-111
9. Roomi MW, Ivanov V, Kalinovsky T, et al. Suppression of human cervical cancer cell lines HeLa and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract. Int J Gynecol Cancer 2006; 16: 1241-1247 (Pubitemid 43886752)
10. Netke SP, Roomi MW, Roomi NW, et al. A specific combination of ascorbic acid, lysine, proline and epigallocatechin gallate inhibits proliferation and extracellular matrix invasion of various human cancer cell lines. Res Commun Pharmacol Toxicol Emerg Drugs 2003; 2: 37-50.
11. Kawakami S, Kageyama Y, Fujii Y, et al. Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells. Anticancer Res 2001; 21: 213-219 (Pubitemid 32267645)
12. Morini M, Cai T, Aluigi MG, et al. The role of the thiol N-acetylcysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers 1999; 14: 268-271 (Pubitemid 30064181)
13. Noonan DM, Benelli R, Albini A. Angiogenesis and cancer prevention: a vision. Recent Results Cancer Res 2007; 174: 219-224
14. Yoon SO, Kim MM, Chung AS. Inhibitory effect of selenite on invasion of HT1080 tumor cells. J Biol Chem 2001; 276: 20085-20092 (Pubitemid 37411078)
15. Maramag C, Menon M, Balaji KC, et al. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis. Prostate 1997; 32: 188-195
16. Hara Y. Green tea: health benefits and applications book. NY: CRC, USA 2001 [91-111 p].
17. Chen D, Daniel KG, Kuhn DJ, et al. Green tea and tea polyphenols in cancer prevention. Front Biosci 2004; 9: 2618-2631
18. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997; 48: 489-509. (Pubitemid 27101848)
19. Roomi MW, Ivanov V, Kalinovsky T, et al. Inhibition of cell invasion and MMP production by a nutrient mixture in malignant liposarcoma cell line SW-872. Med Oncol 2007; 24: 394-401. (Pubitemid 350135932)
20. Schorah A. Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer 1982; 46: 354-367
21. Kurbacher CM, Wagner U, Kolster B, et al. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett 1996; 103: 183-189 (Pubitemid 26147697)
22. Roomi MW, House D, Eckert-Maksić M, et al. Growth suppression of malignant leukemia cell line in vitro by ascorbic acid (vitamin C) and its derivatives. Cancer Lett 1998; 122: 93-99
23. Liu JW, Nagao N, Kageyama K, et al. Antimetastatic and anti-invasive ability of phospho-ascorbyl palmitate through intracellular ascorbate enrichment and the resultant antioxidant action. Proc Natl Acad Sci USA 1976; 73: 3685-3689
24. Ahmad N, Feyes DK, Nieminen AL, et al. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997; 89: 1881-1886 (Pubitemid 28009824)
25. Roy M, Chakrabarty S, Sinha D, et al. Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: a green tea polyphenol. Mutat Res 2003; 523-524: 33-41. (Pubitemid 36293230)
26. Jariwalla RJ, Gangapurkar B, Nakamura D. Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium. Br J Nutr 2009; 101: 182-189
27. Bertolini F, Fusetti L, Rabascio C, et al. Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma. Leukemia 2000; 14: 1477-1482 (Pubitemid 30601356)
28. Citak EC, Oguz A, Karadeniz C, et al. Role of gelatinases (MMP-2 and MMP-9), TIMP-1, vascular endothelial growth factor (VEGF), and microvessel density on the clinicopathological behavior of childhood non-Hodgkin lymphoma. Pediatr Hematol Oncol 2008; 25: 55-66. (Pubitemid 351168921)
29. Shanafelt TD, Call TG, Zent CS, et al. Phase I trial of daily oral polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol 2009; 27: 3808-3814
30. Kossakowska AE, Huchcroft SA, Urbanski SJ, et al. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer 1996; 73: 1401-1408 (Pubitemid 126425209)
31. Weinthal JA, Goldman SC, Lenarsky C. Successful treatment of relapsed Burkitt's lymphoma using unrelated cord blood transplantation as consolidation therapy. Bone Marrow Transplant 2000; 25: 1311-1313 (Pubitemid 30428149)